首页> 外文期刊>Respiration: International Review of Thoracic Diseases >Antiproliferative properties of human alveolar macrophages.
【24h】

Antiproliferative properties of human alveolar macrophages.

机译:人肺泡巨噬细胞的抗增殖特性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of our study was to determine whether macrophages from lung cancer patients could acquire antitumoral properties in an in vitro model. METHODS: We isolated macrophages from bronchoalveolar lavages performed in two groups of patients: patients with lung cancer and patients with lung infection. All patients were smokers. We used the inhibition of incorporation of 3H-thymidine by U937 tumoral cells as an in vitro cytostatic assay. RESULTS: When stimulated by gamma interferon, alveolar macrophages either from lung cancer patients or from patients with lung infection induced cytostasis of proliferating U937 tumoral cells. This effect could be reproduced by using the supernatants of cultures of activated macrophages. When using optimal doses, gamma interferon showed an increased activity as compared with lipopolysaccharide. The combination of these two compounds was no more effective than gamma interferon alone in cancer patients. A macrophage/U937 tumoral cell ratio of 1/1 was sufficient to achieve a near-maximal cytostatic effect. CONCLUSIONS: Our results demonstrate that it is possible to activate, in vitro, alveolar macrophages from lung cancer patients by stimulation with gamma interferon. These macrophages acquire antiproliferative properties against a sensitive tumoral cell line.
机译:目的:我们的研究目的是确定肺癌患者的巨噬细胞是否可以在体外模型中获得抗肿瘤特性。方法:我们从两组患者的支气管肺泡灌洗液中分离出巨噬细胞:肺癌患者和肺部感染患者。所有患者均为吸烟者。我们将U937肿瘤细胞对3H-胸苷掺入的抑制作用用作体外细胞抑制试验。结果:当被γ干扰素刺激时,来自肺癌患者或患有肺部感染的患者的肺泡巨噬细胞诱导增殖的U937肿瘤细胞的细胞停滞。通过使用活化的巨噬细胞培养物的上清液可以再现这种效果。当使用最佳剂量时,与脂多糖相比,γ干扰素显示出增加的活性。这两种化合物的组合在癌症患者中没有比单独使用γ-干扰素更有效的方法。巨噬细胞/ U937肿瘤细胞比率为1/1,足以达到接近最大的细胞抑制作用。结论:我们的结果表明,通过γ干扰素的刺激可以体外活化肺癌患者的肺泡巨噬细胞。这些巨噬细胞获得抗敏感肿瘤细胞系的抗增殖特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号